S
Shukra Pharmaceuticals Ltd
BSE:524632
Shukra Pharmaceuticals Ltd
BSE:524632
Price:
35.35
INR
4.99%
Market Cap:
₹15.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shukra Pharmaceuticals Ltd
BSE:524632
|
IN |
|
T
|
TTK Healthcare Ltd
BSE:507747
|
IN |
|
LX Hausys Ltd
KRX:108670
|
KR |
|
Odontoprev SA
BOVESPA:ODPV3
|
BR |
Income Statement
Earnings Waterfall
Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd
Income Statement
Shukra Pharmaceuticals Ltd
Shukra Pharmaceuticals Ltd
Currency: INR
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
241
N/A
|
248
+3%
|
242
-2%
|
588
+143%
|
724
+23%
|
933
+29%
|
1 099
+18%
|
746
-32%
|
576
-23%
|
385
-33%
|
302
-22%
|
326
+8%
|
348
+7%
|
351
+1%
|
637
+81%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(136)
|
(124)
|
(125)
|
(453)
|
(592)
|
(754)
|
(824)
|
(445)
|
(266)
|
(113)
|
(80)
|
(81)
|
(89)
|
(85)
|
(117)
|
|
| Gross Profit |
105
N/A
|
124
+18%
|
118
-5%
|
135
+15%
|
132
-2%
|
179
+36%
|
275
+53%
|
301
+9%
|
310
+3%
|
272
-12%
|
222
-18%
|
245
+10%
|
259
+6%
|
266
+3%
|
520
+95%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(86)
|
(81)
|
(77)
|
(100)
|
(90)
|
(92)
|
(96)
|
(127)
|
(134)
|
(142)
|
(150)
|
(148)
|
(158)
|
(177)
|
(200)
|
|
| Selling, General & Administrative |
(52)
|
(52)
|
(53)
|
(49)
|
0
|
(38)
|
(39)
|
(56)
|
(57)
|
(57)
|
(59)
|
(115)
|
(66)
|
(73)
|
(84)
|
|
| Depreciation & Amortization |
(17)
|
(18)
|
(19)
|
(18)
|
(19)
|
(20)
|
(20)
|
(21)
|
(23)
|
(24)
|
(26)
|
(30)
|
(31)
|
(32)
|
(34)
|
|
| Other Operating Expenses |
(17)
|
(11)
|
(6)
|
(33)
|
(71)
|
(35)
|
(36)
|
(50)
|
(54)
|
(60)
|
(64)
|
(2)
|
(61)
|
(72)
|
(82)
|
|
| Operating Income |
19
N/A
|
42
+122%
|
41
-4%
|
35
-13%
|
42
+20%
|
87
+107%
|
179
+106%
|
174
-3%
|
176
+2%
|
131
-26%
|
73
-44%
|
97
+34%
|
101
+4%
|
89
-12%
|
320
+259%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(4)
|
(4)
|
(4)
|
(3)
|
(16)
|
(16)
|
(16)
|
(3)
|
(3)
|
(3)
|
(4)
|
10
|
(8)
|
(10)
|
(11)
|
|
| Total Other Income |
(1)
|
(25)
|
(24)
|
12
|
18
|
20
|
23
|
28
|
29
|
37
|
41
|
27
|
46
|
53
|
51
|
|
| Pre-Tax Income |
14
N/A
|
13
-5%
|
13
-3%
|
44
+246%
|
44
+0%
|
91
+106%
|
186
+104%
|
199
+7%
|
203
+2%
|
164
-19%
|
110
-33%
|
133
+21%
|
139
+4%
|
132
-5%
|
360
+172%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(4)
|
(2)
|
(2)
|
(0)
|
1
|
(0)
|
(1)
|
(13)
|
(17)
|
(20)
|
(28)
|
(38)
|
(38)
|
(13)
|
(68)
|
|
| Income from Continuing Operations |
10
|
11
|
11
|
44
|
45
|
91
|
185
|
185
|
186
|
144
|
82
|
96
|
101
|
120
|
292
|
|
| Net Income (Common) |
10
N/A
|
11
+5%
|
11
-2%
|
44
+309%
|
45
+2%
|
91
+103%
|
185
+103%
|
185
+0%
|
186
+0%
|
144
-22%
|
82
-43%
|
96
+17%
|
101
+6%
|
120
+18%
|
292
+144%
|
|
| EPS (Diluted) |
0.03
N/A
|
0.03
N/A
|
0.03
N/A
|
0.65
+2 067%
|
0.15
-77%
|
0.21
+40%
|
0.42
+100%
|
0.42
N/A
|
0.42
N/A
|
0.32
-24%
|
0.18
-44%
|
0.22
+22%
|
0.19
-14%
|
0.26
+37%
|
0.66
+154%
|
|
Switch to:
Switch to:
See Also
Discover More
